| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.2M | — | +90.9% |
| Cost of Revenue | $6.9M | — | +47.6% |
| Gross Profit | $4.3M | — | +257.9% |
| R&D Expense | $2.0M | — | +5.2% |
| SG&A Expense | $6.1M | — | -23.2% |
| Operating Income | -$4.7M | — | +49.5% |
| Pre-tax Income | -$4.9M | — | +51.4% |
| Income Tax | $5K | — | -58.3% |
| Net Income | -$5.0M | — | +51.4% |
| EPS (Basic) | -$0.43 | — | +65.9% |
| EPS (Diluted) | -$0.43 | — | +65.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.8M | -29.9% | +107.0% |
| Accounts Receivable | $7.4M | +22.6% | -66.7% |
| Inventory | $23.7M | -5.2% | -37.7% |
| Current Assets | $45.3M | -9.2% | -38.1% |
| Total Assets | $54.4M | -9.9% | -37.9% |
| Current Liabilities | $23.9M | +1.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +66.6% |
| Capital Expenditures | $19K | — | — |
| Investing Cash Flow | $312K | — | — |
| Financing Cash Flow | -$2.9M | — | -96.7% |
| Free Cash Flow | -$1.6M | — | +66.2% |
| -47.3% |
| Total Liabilities | $34.6M | -6.6% | -44.9% |
| Stockholders' Equity | $19.8M | -15.0% | -20.2% |